{"transactions":[{"id":705626,"issuer":{"id":7853,"kind":"organization","name":"INTENSITY THERAPEUTICS, INC."},"owners":[{"id":29458,"kind":"person","name":"Talamo Joseph","position":1,"cik":"0001524547","reported_name":"Talamo Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy Common Stock)","published_at":"2026-07-20T20:02:39.000Z","date":"2026-07-16","kind":"grant","planned":false,"acquired":true,"shares":34000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest, subject to the individual's continued service with Intensity Therapeutics, Inc., in four, equal, annual installments, beginning on July 16, 2027."}],"balance_after":34000,"derivative":{"exercise_price":4.9,"exercise_date":"2027-07-16","expiration_date":"2036-07-16","underlying":"Common Stock","underlying_shares":34000},"source":{"system":"sec-edgar","filing":"0001524547-26-000009","document":"wk-form4_1784577756.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1524547/000152454726000009/wk-form4_1784577756.xml","form_type":"4"}},{"id":720761,"issuer":{"id":7853,"kind":"organization","name":"INTENSITY THERAPEUTICS, INC."},"owners":[{"id":29458,"kind":"person","name":"Talamo Joseph","position":1,"cik":"0001524547","reported_name":"Talamo Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 Par Value","published_at":"2026-07-01T20:08:22.000Z","date":"2026-06-30","kind":"grant","planned":false,"acquired":true,"shares":1093,"price":3.485,"value":3809.105,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person is voluntarily reporting the acquisition of shares under the Issuer's Amended and Restated 2024 Employee Stock Purchase Plan (ESPP) in a transaction exempt under Rule 16b-3(c) and Rule 16b-3(d)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on June 30, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"On February 18, 2026, the Issuer effectuated a 1-for-25 reverse split of the Issuer's common stock resulting in a reduction in the number of shares held by the Reporting Person. In addition, proportionate adjustments were made to the Issuer's outstanding equity awards. Accordingly, all amounts of securities reported in this Form 4 have been adjusted to reflect the 1-for-25 reverse split."}],"balance_after":2239,"source":{"system":"sec-edgar","filing":"0001524547-26-000007","document":"wk-form4_1782936500.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1524547/000152454726000007/wk-form4_1782936500.xml","form_type":"4"}},{"id":950307,"issuer":{"id":7853,"kind":"organization","name":"INTENSITY THERAPEUTICS, INC."},"owners":[{"id":29458,"kind":"person","name":"Talamo Joseph","position":1,"cik":"0001524547","reported_name":"Talamo Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 Par Value","published_at":"2026-01-05T21:01:45.000Z","date":"2025-12-31","kind":"grant","planned":false,"acquired":true,"shares":14482,"price":0.262,"value":3794.284,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person is voluntarily reporting the acquisition of shares under the Issuer's 2024 Employee Stock Purchase Plan (ESPP) in a transaction exempt under Rule 16b-3(c) and Rule 16b-3(d)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on July 1, 2025."}],"balance_after":28661,"source":{"system":"sec-edgar","filing":"0001524547-26-000003","document":"wk-form4_1767646901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1524547/000152454726000003/wk-form4_1767646901.xml","form_type":"4"}},{"id":1094402,"issuer":{"id":7853,"kind":"organization","name":"INTENSITY THERAPEUTICS, INC."},"owners":[{"id":29458,"kind":"person","name":"Talamo Joseph","position":1,"cik":"0001524547","reported_name":"Talamo Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 Par Value","published_at":"2025-07-02T20:02:22.000Z","date":"2025-06-30","kind":"grant","planned":false,"acquired":true,"shares":14179,"price":0.261,"value":3700.719,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person is voluntarily reporting the acquisition of shares under the Issuer's 2024 Employee Stock Purchase Plan (ESPP) in a transaction exempt under Rule 16b-3(c) and Rule 16b-3(d)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on June 30, 2025."}],"balance_after":14179,"source":{"system":"sec-edgar","filing":"0001567264-25-000065","document":"wk-form4_1751486535.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1524547/000156726425000065/wk-form4_1751486535.xml","form_type":"4"}},{"id":1157142,"issuer":{"id":7853,"kind":"organization","name":"INTENSITY THERAPEUTICS, INC."},"owners":[{"id":29458,"kind":"person","name":"Talamo Joseph","position":1,"cik":"0001524547","reported_name":"Talamo Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy Common Stock)","published_at":"2025-05-06T20:03:44.000Z","date":"2025-05-02","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest, subject to the individual's continued employment with Intensity Therapeutics, Inc., in five, equal, annual installments, beginning on May 2, 2025."}],"balance_after":300000,"derivative":{"exercise_price":0.57,"expiration_date":"2035-05-02","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001567264-25-000027","document":"wk-form4_1746561816.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1524547/000156726425000027/wk-form4_1746561816.xml","form_type":"4"}},{"id":1382323,"issuer":{"id":7853,"kind":"organization","name":"INTENSITY THERAPEUTICS, INC."},"owners":[{"id":29458,"kind":"person","name":"Talamo Joseph","position":1,"cik":"0001524547","reported_name":"Talamo Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy Common Stock)","published_at":"2024-10-23T20:21:12.000Z","date":"2024-10-21","kind":"grant","planned":false,"acquired":true,"shares":427379,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest, subject to the individual's continued employment with Intensity Therapeutics, Inc., in five, equal, annual installments, beginning on October 21, 2024."}],"balance_after":427379,"derivative":{"exercise_price":3.44,"expiration_date":"2034-10-21","underlying":"Common Stock","underlying_shares":427379},"source":{"system":"sec-edgar","filing":"0001524547-24-000002","document":"wk-form4_1729714866.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1524547/000152454724000002/wk-form4_1729714866.xml","form_type":"4"}},{"id":1713703,"issuer":{"id":7853,"kind":"organization","name":"INTENSITY THERAPEUTICS, INC."},"owners":[{"id":29458,"kind":"person","name":"Talamo Joseph","position":1,"cik":"0001524547","reported_name":"Talamo Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy Common Stock)","published_at":"2023-12-12T13:17:04.000Z","date":"2023-12-11","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest, subject to the individual's continued employment with Intensity Therapeutics, Inc., in four equal, annual installments, beginning on December 11, 2024."}],"balance_after":80000,"derivative":{"exercise_price":6.88,"expiration_date":"2033-12-11","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001213900-23-094886","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1524547/000121390023094886/ownership.xml","form_type":"4"}},{"id":3311223,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":29458,"kind":"person","name":"Talamo Joseph","position":1,"cik":"0001524547","reported_name":"Talamo Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and CFO"}}],"security":"Stock Options (Right to Buy)","published_at":"2020-01-15T21:06:59.000Z","date":"2020-01-13","kind":"grant","acquired":true,"shares":29000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-fourth of the shares underlying the stock options vest immediately on the grant date, with an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date."}],"balance_after":29000,"derivative":{"exercise_price":3.28,"exercise_date":"2020-01-13","expiration_date":"2030-01-13","underlying":"Common Stock","underlying_shares":29000},"source":{"system":"sec-edgar","filing":"0001524547-20-000005","document":"wf-form4_157912240103290.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/320017/000152454720000005/wf-form4_157912240103290.xml","form_type":"4"}},{"id":3311222,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":29458,"kind":"person","name":"Talamo Joseph","position":1,"cik":"0001524547","reported_name":"Talamo Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and CFO"}}],"security":"Common Stock","published_at":"2020-01-15T21:06:59.000Z","date":"2020-01-14","kind":"tax_withholding","acquired":false,"shares":2190,"price":3.38,"value":7402.2,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 25,575 unvested restricted stock awards."}],"balance_after":59644,"source":{"system":"sec-edgar","filing":"0001524547-20-000005","document":"wf-form4_157912240103290.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/320017/000152454720000005/wf-form4_157912240103290.xml","form_type":"4"}},{"id":3311221,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":29458,"kind":"person","name":"Talamo Joseph","position":1,"cik":"0001524547","reported_name":"Talamo Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and CFO"}}],"security":"Common Stock","published_at":"2020-01-15T21:06:59.000Z","date":"2020-01-13","kind":"tax_withholding","acquired":false,"shares":2601,"price":3.28,"value":8531.28,"ownership":{"direct":true},"balance_after":61834,"source":{"system":"sec-edgar","filing":"0001524547-20-000005","document":"wf-form4_157912240103290.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/320017/000152454720000005/wf-form4_157912240103290.xml","form_type":"4"}},{"id":3311220,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":29458,"kind":"person","name":"Talamo Joseph","position":1,"cik":"0001524547","reported_name":"Talamo Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and CFO"}}],"security":"Common Stock","published_at":"2020-01-15T21:06:59.000Z","date":"2020-01-13","kind":"grant","acquired":true,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 19,000 restricted stock awards granted under the Issuer's 2018 Equity Incentive Compensation Plan. The restricted stock awards vest in four equal installments, with one-fourth of the shares vesting on the date of grant and an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date."}],"balance_after":64435,"source":{"system":"sec-edgar","filing":"0001524547-20-000005","document":"wf-form4_157912240103290.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/320017/000152454720000005/wf-form4_157912240103290.xml","form_type":"4"}},{"id":3314797,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":29458,"kind":"person","name":"Talamo Joseph","position":1,"cik":"0001524547","reported_name":"Talamo Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and CFO"}}],"security":"Common Stock","published_at":"2020-01-09T21:06:51.000Z","date":"2020-01-08","kind":"tax_withholding","acquired":false,"shares":1821,"price":2.83,"value":5153.43,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 15,325 unvested restricted stock."}],"balance_after":45435,"source":{"system":"sec-edgar","filing":"0001524547-20-000003","document":"wf-form4_157860399368878.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/320017/000152454720000003/wf-form4_157860399368878.xml","form_type":"4"}},{"id":3695062,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":29458,"kind":"person","name":"Talamo Joseph","position":1,"cik":"0001524547","reported_name":"Talamo Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and CFO"}}],"security":"Stock Options (Right to Buy)","published_at":"2019-01-16T21:22:27.000Z","date":"2019-01-14","kind":"grant","acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-fourth of the shares underlying the stock options vest immediately on the grant date, with an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date."}],"balance_after":24000,"derivative":{"exercise_price":4.95,"exercise_date":"2019-01-14","expiration_date":"2029-01-14","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001524547-19-000009","document":"wf-form4_154767373106213.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/320017/000152454719000009/wf-form4_154767373106213.xml","form_type":"4"}},{"id":3695061,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":29458,"kind":"person","name":"Talamo Joseph","position":1,"cik":"0001524547","reported_name":"Talamo Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and CFO"}}],"security":"Common Stock","published_at":"2019-01-16T21:22:27.000Z","date":"2019-01-14","kind":"tax_withholding","acquired":false,"shares":2159,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 18,650 unvested restricted stock awards."}],"balance_after":47256,"source":{"system":"sec-edgar","filing":"0001524547-19-000009","document":"wf-form4_154767373106213.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/320017/000152454719000009/wf-form4_154767373106213.xml","form_type":"4"}},{"id":3695060,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":29458,"kind":"person","name":"Talamo Joseph","position":1,"cik":"0001524547","reported_name":"Talamo Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and CFO"}}],"security":"Common Stock","published_at":"2019-01-16T21:22:27.000Z","date":"2019-01-14","kind":"grant","acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 16,000 restricted stock awards granted under the Issuer's 2018 Equity Incentive Compensation Plan. The restricted stock awards vest in four equal installments, with one-fourth of the shares vesting on the date of grant and an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date."}],"balance_after":49415,"source":{"system":"sec-edgar","filing":"0001524547-19-000009","document":"wf-form4_154767373106213.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/320017/000152454719000009/wf-form4_154767373106213.xml","form_type":"4"}},{"id":3698607,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":29458,"kind":"person","name":"Talamo Joseph","position":1,"cik":"0001524547","reported_name":"Talamo Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and CFO"}}],"security":"Common Stock","published_at":"2019-01-10T17:42:31.000Z","date":"2019-01-08","kind":"tax_withholding","acquired":false,"shares":1795,"price":4.64,"value":8328.8,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 6,650 shares of unvested restricted stock."}],"balance_after":33415,"source":{"system":"sec-edgar","filing":"0001524547-19-000006","document":"wf-form4_154714213392249.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/320017/000152454719000006/wf-form4_154714213392249.xml","form_type":"4"}},{"id":3886617,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":29458,"kind":"person","name":"Talamo Joseph","position":1,"cik":"0001524547","reported_name":"Talamo Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and CFO"}}],"security":"Common Stock","published_at":"2018-06-21T20:30:30.000Z","date":"2018-06-20","kind":"tax_withholding","acquired":false,"shares":6407,"price":8.64,"value":55356.48,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 9,975 shares of unvested restricted stock."}],"balance_after":35210,"source":{"system":"sec-edgar","filing":"0000320017-18-000078","document":"wf-form4_152961301286128.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/320017/000032001718000078/wf-form4_152961301286128.xml","form_type":"4"}},{"id":3886616,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":29458,"kind":"person","name":"Talamo Joseph","position":1,"cik":"0001524547","reported_name":"Talamo Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and CFO"}}],"security":"Common Stock","published_at":"2018-06-21T20:30:30.000Z","date":"2018-06-20","kind":"grant","acquired":true,"shares":13300,"price":8.64,"value":114912.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reflects 13,300 in performance rights, the criteria for which was satisfied on April 6, 2018 and which vested in full on June 20, 2018, when the shareholders voted to approve the new 2018 Equity Incentive Compensation Plan."}],"balance_after":41617,"source":{"system":"sec-edgar","filing":"0000320017-18-000078","document":"wf-form4_152961301286128.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/320017/000032001718000078/wf-form4_152961301286128.xml","form_type":"4"}},{"id":3966526,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":29458,"kind":"person","name":"Talamo Joseph","position":1,"cik":"0001524547","reported_name":"Talamo Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and CFO"}}],"security":"Performance Rights","published_at":"2018-04-10T22:57:39.000Z","date":"2018-04-06","kind":"grant","acquired":true,"shares":13300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance right represents a contingent right to receive one share of common stock of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The performance criteria was satisfied on April 6, 2018 and the performance right shall vest in full on the date of stockholder approval of a new or amended equity plan provided that such approval is obtained on or prior to August 30, 2018 and if not obtained by such date this performance right shall terminate (the \"Vesting Date\")."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The performance criteria was satisfied on April 6, 2018 and the performance right shall vest in full on the date of stockholder approval of a new or amended equity plan provided that such approval is obtained on or prior to August 30, 2018 and if not obtained by such date this performance right shall terminate (the \"Vesting Date\")."}],"balance_after":13300,"derivative":{"underlying":"Common Stock","underlying_shares":13300},"source":{"system":"sec-edgar","filing":"0001144204-18-020001","document":"tv490822_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/320017/000114420418020001/tv490822_4.xml","form_type":"4"}},{"id":4102471,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":29458,"kind":"person","name":"Talamo Joseph","position":1,"cik":"0001524547","reported_name":"Talamo Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and CFO"}}],"security":"Stock Option","published_at":"2018-01-10T21:06:45.000Z","date":"2018-01-08","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-third of the shares underlying the stock options vest immediately on the grant date, with an additional one-third vesting on each of the first and second anniversaries of the grant date."}],"balance_after":20000,"derivative":{"exercise_price":3.79,"exercise_date":"2018-01-08","expiration_date":"2028-01-08","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001144204-18-001703","document":"tv483052_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/320017/000114420418001703/tv483052_4.xml","form_type":"4"}},{"id":4102470,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":29458,"kind":"person","name":"Talamo Joseph","position":1,"cik":"0001524547","reported_name":"Talamo Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and CFO"}}],"security":"Common Stock","published_at":"2018-01-10T21:06:45.000Z","date":"2018-01-08","kind":"tax_withholding","acquired":false,"shares":1803,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 9,975 shares of unvested restricted stock."}],"balance_after":28317,"source":{"system":"sec-edgar","filing":"0001144204-18-001703","document":"tv483052_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/320017/000114420418001703/tv483052_4.xml","form_type":"4"}},{"id":4102469,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":29458,"kind":"person","name":"Talamo Joseph","position":1,"cik":"0001524547","reported_name":"Talamo Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and CFO"}}],"security":"Common Stock","published_at":"2018-01-10T21:06:45.000Z","date":"2018-01-08","kind":"grant","acquired":true,"shares":13300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 13,300 shares of restricted stock granted under the Issuer's 2015 Equity Compensation Plan. The restricted stock vests in three equal installments, with one-third of the shares vesting on the date of grant and an additional one-third vesting on each of the first and second anniversaries of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 9,975 shares of unvested restricted stock."}],"balance_after":30120,"source":{"system":"sec-edgar","filing":"0001144204-18-001703","document":"tv483052_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/320017/000114420418001703/tv483052_4.xml","form_type":"4"}},{"id":4310972,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":29458,"kind":"person","name":"Talamo Joseph","position":1,"cik":"0001524547","reported_name":"Talamo Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and CFO"}}],"security":"Common Stock","published_at":"2017-05-22T20:28:14.000Z","date":"2017-05-18","kind":"tax_withholding","acquired":false,"shares":5982,"price":5.13,"value":30687.66,"ownership":{"direct":true},"balance_after":15619,"source":{"system":"sec-edgar","filing":"0001144204-17-028881","document":"v467614_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/320017/000114420417028881/v467614_4.xml","form_type":"4"}},{"id":4343982,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":29458,"kind":"person","name":"Talamo Joseph","position":1,"cik":"0001524547","reported_name":"Talamo Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and CFO"}}],"security":"Common Stock","published_at":"2017-04-27T20:23:25.000Z","date":"2017-04-25","kind":"tax_withholding","acquired":false,"shares":214,"price":4.74,"value":1014.36,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 14,003 shares of unvested restricted stock."}],"balance_after":21601,"source":{"system":"sec-edgar","filing":"0001144204-17-022666","document":"v465292_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/320017/000114420417022666/v465292_form4.xml","form_type":"4"}},{"id":4479769,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":29458,"kind":"person","name":"Talamo Joseph","position":1,"cik":"0001524547","reported_name":"Talamo Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2017-01-27T22:05:07.000Z","date":"2017-01-25","kind":"tax_withholding","acquired":false,"shares":239,"price":3.87,"value":924.93,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 14,613 shares of unvested restricted stock."}],"balance_after":21812,"source":{"system":"sec-edgar","filing":"0001144204-17-004360","document":"v457629_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/320017/000114420417004360/v457629_4.xml","form_type":"4"}},{"id":4493442,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":29458,"kind":"person","name":"Talamo Joseph","position":1,"cik":"0001524547","reported_name":"Talamo Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and CFO"}}],"security":"Stock Option","published_at":"2017-01-11T22:48:40.000Z","date":"2017-01-09","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"25% of the shares underlying the stock options vest immediately on the grant date and the remaining 75% of the shares underlying the stock options will vest annually over the following three years."}],"balance_after":20000,"derivative":{"exercise_price":3.54,"exercise_date":"2017-01-09","expiration_date":"2027-01-09","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001144204-17-001860","document":"v456766_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/320017/000114420417001860/v456766_4.xml","form_type":"4"}},{"id":4493441,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":29458,"kind":"person","name":"Talamo Joseph","position":1,"cik":"0001524547","reported_name":"Talamo Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and CFO"}}],"security":"Common Stock","published_at":"2017-01-11T22:48:40.000Z","date":"2017-01-09","kind":"tax_withholding","acquired":false,"shares":1672,"price":3.54,"value":5918.88,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 15,088 shares of unvested restricted stock."}],"balance_after":22051,"source":{"system":"sec-edgar","filing":"0001144204-17-001860","document":"v456766_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/320017/000114420417001860/v456766_4.xml","form_type":"4"}},{"id":4493440,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":29458,"kind":"person","name":"Talamo Joseph","position":1,"cik":"0001524547","reported_name":"Talamo Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and CFO"}}],"security":"Common Stock","published_at":"2017-01-11T22:48:40.000Z","date":"2017-01-09","kind":"grant","acquired":true,"shares":13300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 13,300 shares of restricted stock granted under the Issuer's 2015 Equity Compensation Plan. 25% of the shares of restricted stock vest immediately on the grant date and the remaining 75% of the shares of restricted stock will vest annually over the following three years."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 15,088 shares of unvested restricted stock."}],"balance_after":23723,"source":{"system":"sec-edgar","filing":"0001144204-17-001860","document":"v456766_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/320017/000114420417001860/v456766_4.xml","form_type":"4"}},{"id":4561402,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":29458,"kind":"person","name":"Talamo Joseph","position":1,"cik":"0001524547","reported_name":"Talamo Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and CFO"}}],"security":"Common Stock","published_at":"2016-11-10T21:06:37.000Z","date":"2016-10-25","kind":"tax_withholding","acquired":false,"shares":176,"price":4.12,"value":725.12,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 5,254 shares of unvested restricted stock."}],"balance_after":10423,"source":{"system":"sec-edgar","filing":"0001144204-16-133280","document":"v452731_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/320017/000114420416133280/v452731_4.xml","form_type":"4"}},{"id":4592354,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":29458,"kind":"person","name":"Talamo Joseph","position":1,"cik":"0001524547","reported_name":"Talamo Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and CFO"}}],"security":"Stock Option","published_at":"2016-09-30T20:32:39.000Z","date":"2016-09-29","kind":"grant","acquired":true,"shares":13377,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These stock options were granted upon the Company's Compensation Committee approval on September 29, 2016, in consideration of the unpaid portion of the reporting person's discretionary 2015 target bonus."}],"balance_after":13377,"derivative":{"exercise_price":4.77,"exercise_date":"2016-09-29","expiration_date":"2026-09-29","underlying":"Common Stock","underlying_shares":13377},"source":{"system":"sec-edgar","filing":"0001144204-16-126315","document":"v449787_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/320017/000114420416126315/v449787_4.xml","form_type":"4"}}]}